SEC EDGAR · Company announcement
CDW: Leadership change · Company disclosure
Filed 8-K for an event or period dated 2026-10-15. Leadership change; Company disclosure.
Follow CDW- Became public
- Oct 19, 2026, 4:23 PM EDT
- Event / period date
- Oct 15, 2026
- Collected
- Nov 7, 2026, 11:06 PM EST
Why this is connected
This filing identifies CDW Corp as the issuer of the security. The company's SEC identifier connects it to CDW.
Press release dated October 19, 2026, announcing Mr. Balaji’s appointment. ↗Source evidence
Read the source excerpt or record
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 15, 2026, the Board of Directors (the “Board”) of CDW Corporation (the “Company”) increased the number of directors of the Company from nine to ten and appointed Saranga (Sam) Balaji to serve as a director on the Board, effective immediately. Mr. Balaji will serve on the Board’s Audit Committee. The Board has determined that Mr. Balaji is independent for purposes of the listing standards of the Nasdaq Global Select Market. Mr. Balaji will be entitled to a prorated portion of the annual compensation paid to the Company’s non-employee directors. A summary of the compensation the Company provides its non-employee directors is described in the Company’s definitive proxy statement filed with the Securities and Exchange Commission (“SEC”) on April 10, 2026. Furthermore, in connection with his appointment, Mr. Balaji and the Company will enter into the Company’s standard indemnification agreement, the form of which was filed with the SEC as Exhibit 10.32 with the Company’s Amendment No. 2 to Form S-1 filed on June 14, 2013. There are no arrangements or understandings between Mr. Balaji and any other persons pursuant to which he was selected as a director. Mr. Balaji does not have a direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K. Item 7.01. Regulation FD Disclosure. The Company issued a press release on October 19, 2026, announcing the appointment described in Item 5.02, a copy of which is furnished hereto as Exhibit 99.1. Item 9.01. Financial Statements and Exhibits. Exhibit No. Description 99.1 Press release dated October 19, 2026, ann
Congressional trading in CDW
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Sep 10, 2026$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
$1K–$15K · Traded Aug 19, 2026 · disclosed Sep 10, 2026
- Jun 5, 2026$1K–$15K
Rep. April McClain Delaney (D-MD-6)
$1K–$15K · Traded May 19, 2026 · disclosed Jun 5, 2026 · Dependent
- Jun 5, 2026$1K–$15K
Rep. April McClain Delaney (D-MD-6)
$1K–$15K · Traded May 18, 2026 · disclosed Jun 5, 2026 · Dependent
- Jun 5, 2026$1K–$15K
Rep. April McClain Delaney (D-MD-6)
$1K–$15K · Traded May 15, 2026 · disclosed Jun 5, 2026 · Dependent
- Jun 5, 2026$1K–$15K
Rep. April McClain Delaney (D-MD-6)
$1K–$15K · Traded May 14, 2026 · disclosed Jun 5, 2026 · Dependent
- Mar 10, 2026$1K–$15K
Rep. April McClain Delaney (D-MD-6)
$1K–$15K · Traded Feb 24, 2026 · disclosed Mar 10, 2026 · Dependent
- Feb 6, 2026$1K–$15K
- Jan 5, 2026$1K–$15K
Rep. April McClain Delaney (D-MD-6)
$1K–$15K · Traded Dec 5, 2025 · disclosed Jan 5, 2026 · Dependent
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.